SCHEMBL4626503

SCHEMBL4626503

CNC(Cc1ccc2nc(-c3c(Cl)cccc3Cl)ccc2c1)C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 12/20 0.76
ITGAV P06756 4/20 0.76
ITGA4 P13612 7/20 0.48
ITGB7 P26010 4/20 0.48
SCN3A Q9NY46 1/20 0.44
ABL1 P00519 1/20 0.43
ITGA5 P08648 4/20 0.41
PIN1 Q13526 2/20 0.39
MME P08473 2/20 0.38
ITGB3 P05106 2/20 0.38
ACE P12821 1/20 0.38
CPA1 P15085 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13398404 0.89 ITGB1 (0.64) ITGB1ITGAVITGA4ITGB7SCN3A
SCHEMBL4626491 0.87 ITGB1 (0.73) ITGB1ITGAVITGA4ITGB7SCN3A
SCHEMBL3313373 0.86 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL3313356 0.86 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL3316398 0.86 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL8352229 0.86 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL4419511 0.85 ITGB1 (0.83) ITGB1ITGAVITGA4ITGB7SCN3A
SCHEMBL4625481 0.85 ITGB1 (0.54) ITGB1ITGAVPIN1MMEACE
SCHEMBL3318272 0.85 ITGB1 (0.85) ITGB1ITGAVITGA4ITGB7
SCHEMBL4625629 0.84 ITGAV (0.69) ITGB1ITGAVITGA4ITGB7ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP disclosed